RA
GILD icon

RFG Advisory’s Gilead Sciences GILD Stock Holding History

RFG Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-600
Closed -$12K – 86
2015
Q2 		$12K Buy
+600
New +$65.6K 0.01% 164

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

RFG Advisory's GILD Position: Q2 2026 in Review

RFG Advisory increased its Gilead Sciences (GILD) stake by 0.93% in Q2 2026, buying an estimated $15.7K and bringing the position to 12,955 shares worth $1.64M. The position accounts for 0.03% of the portfolio, ranked #423.

RFG Advisory first reported a position in GILD in Q1 2015 and has held it in 44 quarters since. The position peaked at $1.79M in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • RFG Advisory held 12,955 shares of Gilead Sciences worth $1.64M as of Q2 2026.
  • RFG Advisory bought 119 Gilead Sciences shares in Q2 2026, an estimated $15.7K.
  • Gilead Sciences made up 0.03% of RFG Advisory's portfolio in Q2 2026, its #423 holding.
  • RFG Advisory first reported a position in Gilead Sciences in Q1 2015 and has held it in 44 quarters since.
  • RFG Advisory's Gilead Sciences position peaked at $1.79M in Q1 2026.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.